News

Latest

The Centers for Medicare & Medicaid Services delivered close to $34 billion in Medicare accelerated and advance payments to Part A providers, including hospitals, and Part B suppliers to combat resource challenges related to COVID-19, the agency said.
The Creative Coalition, Association for Healthcare Philanthropy, and the AHA launched the “Protect the Heroes” campaign, which allows the general public to make direct impact donations to America’s hospitals and health systems.
The Food and Drug Administration recently issued an enforcement policy allowing certain modifications to expand the availability of devices used in extracorporeal membrane oxygenation therapy during the COVID-19 public health emergency.
To help health care professionals understand the potential risks and benefits of N95 respirator reuse or extended use during the COVID-19 emergency, ECRI updated its clinical evidence assessment on these practices.
AHA General Counsel Melinda Hatton and Jones Day lawyers Cathy Livingston and Robin Overby hosted a webinar on the Small Business Administration’s Paycheck Protection Program.
The Drug Enforcement Agency said it is increasing annual caps for controlled substances whose supplies are in high demand due the COVID-19 crisis.
The Department of Health and Human Services’ Office of the Inspector General says it will seek to ensure health care providers retain regulatory flexibility during the COVID-19 crisis.
The Department of Health and Human Services' Office for Civil Rights April 3 warned HIPAA-covered entities of an individual posing as an OCR investigator attempting to obtain patients’ protected health information.
The federal government will use a portion of the Coronavirus Aid, Relief, and Economic Security Act’s $100 billion emergency fund for hospitals and health care providers to reimburse providers treating uninsured COVID-19 patients, President Trump and Health and Human Services Secretary Alex Azar announced.
The AHA urged CMS to use its authority to extend to LTCHs the 20% hospital add-on payment for Medicare beneficiaries diagnosed with COVID-19, which was authorized by the CARES Act.